Platelet transfusion in neonatal intensive care units of 22 European countries: a prospective observational study
Status PubMed-not-MEDLINE Jazyk angličtina Země Velká Británie, Anglie Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
39669406
PubMed Central
PMC11635195
DOI
10.1016/j.lanepe.2024.101086
PII: S2666-7762(24)00253-9
Knihovny.cz E-zdroje
- Klíčová slova
- Epidemiology, Europe, Neonatal intensive care unit, Neonatology, Platelet transfusion, Preterm infants, Thrombocytopenia,
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Platelet transfusions are given to preterm infants with severe thrombocytopenia aiming to prevent haemorrhage. The PlaNeT2/MATISSE trial revealed higher rates of mortality and/or major bleeding in preterm infants receiving prophylactic platelet transfusions at a platelet count threshold of 50 × 109/L compared to 25 × 109/L. The extent to which this evidence has been incorporated into clinical practice is unknown, thus we aimed to describe current neonatal platelet transfusion practices in Europe. METHODS: We performed a prospective observational study in 64 neonatal intensive care units across 22 European countries between September 2022 and August 2023. Outcome measures included observed transfusion prevalence rates (per country and overall, pooled using a random effects Poisson model), expected rates based on patient-mix (per country, estimated using logistic regression), cumulative incidence of receiving a transfusion by day 28 (with death and discharge considered as competing events), transfusion indications, volumes and infusion rates, platelet count triggers and increment, and adverse effects. FINDINGS: We included 1143 preterm infants, of whom 71 (6.2%, [71/1143]) collectively received 217 transfusions. Overall observed prevalence rate was 0.3 platelet transfusion days per 100 admission days. By day 28, 8.3% (95% CI: 5.5-11.1) of infants received a transfusion. Most transfusions were indicated for threshold (74.2%, [161/217]). Pre-transfusion platelet counts were above 25 × 109/L in 33.1% [53/160] of these transfusions. There was significant variability in volume and duration. INTERPRETATION: The restrictive threshold of 25 × 109/L is being integrated into clinical practice. Research is needed to explore existing variation and generate evidence for various aspects including optimal volumes and infusion rates. FUNDING: Sanquin, EBA, and ESPR.
2 Department of Neonatology Poznan University of Medical Sciences Poznan Poland
Centro Materno Infantil do Norte Unidade Local de Saúde de Santo António Porto Portugal
Charité Universitätsmedizin Berlin Berlin Germany
Department of Neonatology Semmelweis University Budapest Hungary
Faculty of Health Sciences University of Bristol Bristol United Kingdom
Fondazione IRCCS Policlinico San Matteo Pavia Italy
Jessenius Faculty of Medicine University Hospital Martin Martin Slovakia
Karolinska Institute Stockholm Sweden
La Fe University Hospital Valencia Spain
Leiden University Medical Centre Leiden the Netherlands
Medical University Vienna Vienna Austria
National Maternity Hospital Dublin Ireland
NHS Blood and Transplant London United Kingdom
Oslo University Hospital Oslo Norway
Sanquin Research Department of Molecular Cellular Hemostasis Amsterdam the Netherlands
Sanquin Research Sanquin Blood Supply Foundation Amsterdam the Netherlands
University College Dublin Dublin Ireland
University Hospital Centre Zagreb University of Zagreb School of Medicine Zagreb Croatia
University Hospital Hradec Králové Hradec Králové Czech Republic
University Hospital Zurich Zurich Switzerland
University Medical Centre Ljubljana Ljubljana Slovenia
University Medical Centre Sarajevo Sarajevo Bosnia and Herzegovina
University of Ljubljana Faculty of Medicine Ljubljana Slovenia
University of Medicine and Pharmacy Iuliu Hatieganu Cluj Napoca Romania
University of Oxford Oxford United Kingdom
Women's and Children's Division Southmead Hospital North Bristol NHS Trust Bristol United Kingdom
Zobrazit více v PubMed
Curley A., Stanworth S.J., Willoughby K., et al. Randomized trial of platelet-transfusion thresholds in neonates. N Engl J Med. 2019;380(3):242–251. PubMed
Scrivens A., Reibel N.J., Heeger L., et al. Survey of transfusion practices in preterm infants in Europe. Arch Dis Child Fetal Neonatal Ed. 2023;108(4):360–366. PubMed PMC
Stijnen T., Hamza T.H., Ozdemir P. Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data. Stat Med. 2010;29(29):3046–3067. PubMed
Davenport P.E., Chan Yuen J., Briere J., Feldman H.A., Sola-Visner M.C., Leeman K.T. Implementation of a neonatal platelet transfusion guideline to reduce non-indicated transfusions using a quality improvement framework. J Perinatol. 2021;41(6):1487–1494. PubMed PMC
Borges J.P., dos Santos A.M., da Cunha D.H., Mimica A.F., Guinsburg R., Kopelman B.I. Restrictive guideline reduces platelet count thresholds for transfusions in very low birth weight preterm infants. Vox Sang. 2013;104(3):207–213. PubMed
Zabeida A., Chartrand L., Lacroix J., Villeneuve A. Platelet transfusion practice pattern before and after implementation of a local restrictive transfusion protocol in a neonatal intensive care unit. Transfusion. 2023;63(1):134–142. PubMed
Bahr T.M., Christensen T.R., Henry E., et al. Platelet transfusions in a multi-neonatal intensive care unit health care organization before and after publication of the PlaNeT-2 clinical trial. J Pediatr. 2023;257 PubMed
Heeger L.E., Houben N.A.M., Caram-Deelder C., Fustolo-Gunnink S.F., van der Bom J.G., Lopriore E. Impact of restrictive platelet transfusion strategies on transfusion rates: a cohort study in very preterm infants. Transfusion. 2024;64(8):1421–1427. PubMed
Sparger K.A., Assmann S.F., Granger S., et al. Platelet transfusion practices among very-low-birth-weight infants. JAMA Pediatr. 2016;170(7):687–694. PubMed PMC
Fustolo-Gunnink S.F., Huisman E.J., van der Bom J.G., et al. Are thrombocytopenia and platelet transfusions associated with major bleeding in preterm neonates? A systematic review. Blood Rev. 2019;36:1–9. PubMed
Baer V.L., Lambert D.K., Henry E., Christensen R.D. Severe thrombocytopenia in the NICU. Pediatrics. 2009;124(6):e1095–e1100. PubMed
Ballabh P. Intraventricular hemorrhage in premature infants: mechanism of disease. Pediatr Res. 2010;67(1):1–8. PubMed PMC
von Lindern J.S., van den Bruele T., Lopriore E., Walther F.J. Thrombocytopenia in neonates and the risk of intraventricular hemorrhage: a retrospective cohort study. BMC Pediatr. 2011;11:16. PubMed PMC
Muthukumar P., Venkatesh V., Curley A., et al. Severe thrombocytopenia and patterns of bleeding in neonates: results from a prospective observational study and implications for use of platelet transfusions. Transfus Med. 2012;22(5):338–343. PubMed
Stanworth S.J., Clarke P., Watts T., et al. Prospective, observational study of outcomes in neonates with severe thrombocytopenia. Pediatrics. 2009;124(5):e826–e834. PubMed
Patel R.M., Hendrickson J.E., Nellis M.E., et al. Variation in neonatal transfusion practice. J Pediatr. 2021;235:92–99.e4. PubMed PMC
van der Staaij H., Stanworth S.J., Fustolo-Gunnink S.F. Prophylactic platelet transfusions: why less is more. Clin Perinatol. 2023;50(4):775–792. PubMed
Moore C.M., D’Amore A., Fustolo-Gunnink S., et al. Two-year outcomes following a randomised platelet transfusion trial in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2023;108(5):452–457. PubMed PMC
Thomas S. Platelets: handle with care. Transfus Med. 2016;26(5):330–338. PubMed
Sahota G., Munir T., Chang C. Platelet transfusions. BMJ. 2011;343
Kalteren W.S., Bos A.F., Bergman K.A., van Oeveren W., Hulscher J.B.F., Kooi E.M.W. The short-term effects of RBC transfusions on intestinal injury in preterm infants. Pediatr Res. 2023;93(5):1307–1313. PubMed PMC
Dannaway D.C., Noori S. A randomized trial of platelet transfusions over 30 vs 120 minutes: is there an effect on post-transfusion platelet counts? J Perinatol. 2013;33(9):703–706. PubMed
Moore C.M., Curley A.E. Neonatal platelet transfusions: starting again. Transfus Med Rev. 2021;35(3):29–35. PubMed
Bassan H. Intracranial hemorrhage in the preterm infant: understanding it, preventing it. Clin Perinatol. 2009;36(4):737–762. PubMed
Honohan A., van’t Ende E., Hulzebos C., et al. Posttransfusion platelet increments after different platelet products in neonates: a retrospective cohort study. Transfusion. 2013;53(12):3100–3109. PubMed
European Commission Directorate-General for Health and Food Safety . 2023. Summary of the 2022 annual reporting of serious adverse reactions and events for blood and blood components.
Strauss R.G. Platelet transfusions in neonates: questions and answers. Expert Rev Hematol. 2010;3(1):7–9. PubMed
Davenport P., Sola-Visner M. Platelet transfusions in neonates: beyond hemostasis. Arterioscler Thromb Vasc Biol. 2023;43(6):886–888. PubMed PMC
McFadyen J.D., Kaplan Z.S. Platelets are not just for clots. Transfus Med Rev. 2015;29(2):110–119. PubMed
Waubert de Puiseau M., Sciesielski L.K., Meyer O., et al. Pooling, room temperature, and extended storage time increase the release of adult-specific biologic response modifiers in platelet concentrates: a hidden transfusion risk for neonates? Transfusion. 2020;60(8):1828–1836. PubMed
Bahr T.M., Snow G.L., Christensen T.R., et al. Can red blood cell and platelet transfusions have a pathogenic role in bronchopulmonary dysplasia? J Pediatr. 2024;265 PubMed
Moore C.M., O’Reilly D., McCallion N., Curley A.E. Changes in inflammatory proteins following platelet transfusion in a neonatal population. Pediatr Res. 2023;94(6):1973–1977. PubMed PMC
Davenport P., Sola-Visner M. Hemostatic challenges in neonates. Front Pediatr. 2021;9 PubMed PMC
O'Reilly D., Murphy C.A., Drew R., et al. Platelets in pediatric and neonatal sepsis: novel mediators of the inflammatory cascade. Pediatr Res. 2022;91(2):359–367. PubMed PMC
Maurya P., Ture S.K., Li C., et al. Transfusion of adult, but not neonatal, platelets promotes monocyte trafficking in neonatal mice. Arterioscler Thromb Vasc Biol. 2023;43(6):873–885. PubMed PMC
Davenport P., Soule-Albridge E., Sola-Visner M. Hemostatic and immunologic effects of platelet transfusions in neonates. Clin Perinatol. 2023;50(4):793–803. PubMed